MDS and the failed signaling through the ATM-Chk2 pathway and the lack of involvement of the MRN complex in DDR to TMZ may all contribute to the increased clonogenic survival that we have observed in the TMZ-resistant GBM cells. The gene discussed is CHEK2; the disease is myelodysplastic syndrome.